Best Healthcare Companies in Grand Est, France
The 36 best Healthcare companies in Grand Est, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Biosynex.
Ranked: Best Healthcare companies in Grand Est
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Biosynex Manufacturers professional rapid diagnostics and self-diagnostics for range of diseases | $3M | 122 mo ago | Public | — | 2005 | WordPress Block EditorWordPressMySQL+18 | 25 patents Medical temperature measurement devices and sample collection systems for obstetric diagnostics. | — |
| 2 | Abiolab Provider of water, air, and food analysis services through accredited laboratories | $2M | 104 mo ago | Acquired | Juan Bardallo Proprietor | 2015 | — | — | — |
| 3 | Freeness Chain of fitness centers | $2M | 137 mo ago | Seed | Michel Broussard President & CEO | 2009 | — | — | — |
| 4 | Inoviem Scientific CRO specializing in researching drug-target interaction for discovering new therapeutics | $1M | 113 mo ago | Seed | — | 2011 | — | — | — |
| 5 | Juggle Provider of software development, artificial intelligence, and other services related to healthcare sectors | $999K | 48 mo ago | Seed | — | 2018 | — | — | — |
| 6 | StaniPharm CDMO focused on manufacturing of drugs nano-particles | $811K | 77 mo ago | Funding Raised | Frantz Deschamps Co-Founder | 2010 | — | 5 patents Formulation of fine‑particle pharmaceutical active ingredients | — |
| 7 | Rhenovia Pharma Provider of biosimulation technology for CNS drug discovery and development | $728K | 151 mo ago | Series B | Serge Bischoff President & CEO | 2007 | — | — | — |
| 8 | Synerlab Contract development and manufacturing organization | $604K | 68 mo ago | Acquired | — | 2000 | — | — | — |
| 9 | Novalix Provider of preclinical contract research services for drug discovery and cosmetics | — | 25 mo ago | Seed | Jean-Paul Renaud Co-Founder | 2002 | WordPressApple iCloud MailMicrosoft 365+19 | 4 patents Small-molecule METTL3 epigenetic writer inhibitors and potassium channel opener therapeutics | 1 award |
Top 10 Healthcare companies in Grand Est
#1
Seed · Nancy, Grand Est · founded 2018 · 9 employees$998.7Kraised▾
Developer of a visualization software designed to assist multidisciplinary teams in writing postscripts. The company's software tracks the most relevant information in one click and visualizes at a glance the acquisition path, skill after skill, in the natural order of development, enabling patients diagnosed with neurodevelopmental disorders to evaluate the projects and reports in a simple way.
- Sep 2022Seed$998.7K
#2
Acquired · Saint Martin, Grand Est · founded 2015 · 120 employees$2.4Mraised▾
Abiolab is a group of laboratories specializing in water, air, and food analysis. They have an online client portal for accessing their services and offer accreditation through COFRAC. They also provide employment opportunities in the field.
- Jan 2018Seed$2.4M
#3
Public · Strasbourg, Grand Est · founded 2005 · 300 employees$2.8Mraised▾
Biosynex (previously DIMA) is the manufacturer and provider of rapid membrane tests in the in-vitro diagnostic market. Its professional diagnostic products include Rapid diagnostic tests (RDTs) to detect an infection (HIV, malaria, mononucleosis, tonsillitis), an immune status (tetanus immunity), a physiological situation (pregnancy), an acute pathological situation (rupture of fetal membranes, myocardial infarction) or the presence of drugs in urine or saliva Blot tests (Western Blot or immunoblot) to indicate the presence or absence of antibodies and Real-time PCR (qPCR) enables the quantitative measure of DNA and ARN molecules. It also develops self-diagnostic tests for pregnancy, drug testing, blood pressure and glucose monitoring. It also provides oral care, reading glasses and foot care products.
#4
Seed · Strasbourg, Grand Est · founded 2011 · 13 employees$1.3Mraised▾
Inoviem Scientific offers preclinical and clinical development services to drug developers and offers proprietary technologies to study drug-target interaction. Their preclinical drug discovery services include target identification, hit-to-lead and lead optimization. For clinical development they offer services such as patient stratification (differentiating responders from non-responders in pre-phase I and II trials and post market studies), biomarker identification, selection and validation and biomarker-associated CDx development and drug rescue and drug upgrade (in case of already-marketed drugs and Phase IV studies) services. They have proprietary technologies such as "Nematic Protein Organisation Technique" (NPOT) to isolate and identify protein complexes interacting with exogenous molecules and Physiological Intermolecular Modulation Spectroscopy (PIMS) to study the interactions of drugs and targets under native physiological conditions in real time.
- Apr 2017Seed$693K
- Apr 2017Grant (prize money)$107K
- May 2015Conventional Debt$608K
- Feb 2015Seed$566K
#5
Acquired · Erstein, Grand Est · founded 2000 · 1300 employees$603.9Kraised▾
Synerlab is a contract manufacturing organization operating in the pharmaceutical, dietetic, veterinary, and dietary supplements markets. Services offered include the development of solid oral dosage forms, manufacturing, custom packaging, and more.
- Jan 2021Grant (prize money)$603.9K
- Jul 2017Conventional Debt—
- Dec 2013Conventional Debt—
- Jun 2007PE—
#6
Funding Raised · Champigneulles, Grand Est · founded 2010 · 11 employees$810.8Kraised▾
Operator of a contract development and manufacturing organization intended to offer improved clinical performances over existing formulation. The company's products use Supercritical Fluid (SCF) technology and formulation techniques, enabling life science industries to efficiently move their product along the development path and get high-quality results using cost-effective supercritical fluid technologies.
- Apr 2020Grant (prize money)$810.8K
#7
Seed · Mulhouse, Grand Est · founded 2009 · 48 employees$1.6Mraised▾
Operator of fitness centers intended to offer gym facilities around the clock. The company's fitness centers include a chain of fitness and sports facilities that offers exercise equipment and various workout options for the purpose of physical exercise, enabling users to get personalized coaching services in order to stay fit and healthy.
#8
Series B · Mulhouse, Grand Est · founded 2007$728Kraised▾
Rhenovia is a biopharmaceutical company engaged in biosimulation focussed in drug discovery and development (DD&D) for the nervous system (NS). Rhenovia's goal is to discover technologies and identify better treatments for diseases of the nervous system, focusing first on Alzheimer's disease, depression, schizophrenia, bipolar disorder, epilepsy, stroke, Parkinson's disease, as well as rare/orphan diseases like Huntington's disease. Rhenovia possesses a biosimulation platform directly applicable to CNS Drug discovery and development (DD&D). RHENOMS models excitatory and inhibitory synaptic transmission integrating pre-, intra- and postsynaptic electrical, biophysical and biochemical processes. The first proprietary platform simulates cognitive deficit (long-term potentiation) and other pathologies associated with GLU/GABA homeostasis as well as Ca2+ and acetylcholine deregulation.
- Feb 2014Series B$728K
- Jan 2013Grant (prize money)—
#9
Seed · Strasbourg, Grand Est · founded 2002 · 229 employees—raised▾
Provider of preclinical contract research services for drug discovery and cosmetics. The organization offers chemistry, biophysics, pharmacology, and drug metabolism and pharmacokinetics services. These services support projects from early-stage research through preclinical efficacy. The company provides custom testing options, analytics, and solutions for therapeutic development and cosmetic applications.
- Aug 2024Seed—
#10
Funding Raised · Nancy, Grand Est · founded 2020—raised▾
Non-profit organization that offers therapeutic and ecological services
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.